Obalon Therapeutics Inc. (Nasdaq: OBLN) priced its public offering of approximately 5.4 million common shares at the discounted price of $5.50 per share sending the stock price down 90 cents to close at $5.24.
Obalon Therapeutics prices offering at discount
January 19, 2018 at 17:44 PM EST
